NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Esperite N.V (AS: ESP)

 
ESP Technical Analysis
5
As on 28th Oct 2022 ESP STOCK Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.03 & Strong Sell for SHORT-TERM with Stoploss of 0.04 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ESPSTOCK Price

Open 0.01 Change Price %
High 0.01 1 Day 0.00 0.00
Low 0.01 1 Week 0.00 0.00
Close 0.01 1 Month -0.01 -50.00
Volume 1968024 1 Year -0.03 -75.00
52 Week High 0.04 | 52 Week Low 0.01
 
AS Netherlands Most Active Stocks
RDSA 22.80 -1.08%
KPN 3.71 %
INGA 15.75 %
PHARM 0.81 %
PHIA 25.09 %
MAREL 3.75 %
PRX 40.20 %
AGN 5.90 %
OCI 11.28 %
AD 30.84 %
 
AS Netherlands Top Gainers Stocks
URW 51.24 4.19%
URW 51.24 4.19%
DSC2 8.80 2.33%
CLB 21.00 0.96%
CLB 21.00 0.96%
CLB 21.00 0.96%
HDG 179.20 0.56%
HDG 179.20 0.56%
HDG 179.20 0.56%
VTA 4.99 0.20%
 
AS Netherlands Top Losers Stocks
DPA 0.10 -16.67%
DPA 0.10 -16.67%
RDSA 22.80 -1.08%
RDSA 22.80 -1.08%
RDSA 22.80 -1.08%
GVNV 28.30 -0.70%
ATRS 2.98 -0.67%
ATRS 2.98 -0.67%
RDSB 22.75 -0.44%
RDSB 22.75 -0.44%
 
 
ESP
Daily Charts
ESP
Intraday Charts
Whats New @
Bazaartrend
ESP
Free Analysis
 
ESP Important Levels Intraday
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
 
ESP Forecast October 2024
4th UP Forecast0.03
3rd UP Forecast0.02
2nd UP Forecast0.02
1st UP Forecast0.02
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast-0.01
 
ESP Weekly Forecast
4th UP Forecast0.01
3rd UP Forecast0.01
2nd UP Forecast0.01
1st UP Forecast0.01
1st DOWN Forecast0.01
2nd DOWN Forecast0.01
3rd DOWN Forecast0.01
4th DOWN Forecast0.01
 
ESP Forecast2024
4th UP Forecast0.07
3rd UP Forecast0.05
2nd UP Forecast0.04
1st UP Forecast0.03
1st DOWN Forecast-0.01
2nd DOWN Forecast-0.02
3rd DOWN Forecast-0.03
4th DOWN Forecast-0.05
 
Esperite N.V ( AS Netherlands Symbol : ESP )
Sector : Healthcare And Other Stocks in Same Sector
 
ESP Other Details
Segment EQ
Market Capital 1892566.00
Sector Healthcare
Industry Medical Care Facilities
Offical website >
 
ESP Address
ESP
 
ESP Latest News
 
Your Comments and Response on Esperite N.V
 
ESP Business Profile
Esperite N.V., together with its subsidiaries, operates as a regenerative and predictive medicine company in the Netherlands, Spain, Italy, Switzerland, and internationally. It operates through four segments: Stem Cell, The Cell Factory, Genoma, and Other. The company collects, processes, and stores human adult stem cells from the umbilical cord blood and the umbilical cord. It also provides proteomics and genomics predictive medicines; and implements its proprietary technology for clinical grade production of autologous mesenchymal and stromal stem cells. In addition, it develops AGAATA, a diagnostic system based on the next generation sequencing technology, as well as allows laboratories to perform their own genetic analysis with the bioinformatics and methods developed by Genoma. The company's products portfolio includes Tranquility, a non-invasive prenatal test; and Cryosave's whole genome sequencing, carrier screening tests, and other products. Further, it engages in biobanking cord blood and cord tissue stem cells business. The company was formerly known as Cryo-Save Group N.V. and changed its name to Esperite N.V. in July 2014. Esperite N.V. was founded in 2000 and is headquartered in Amsterdam, the Netherlands. Address: Herengracht 282, Amsterdam, Netherlands, 1016 BX
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service